Literature DB >> 15778290

Anti-CD3 induces bi-phasic apoptosis in murine intestinal epithelial cells: possible involvement of the Fas/Fas ligand system in different T cell compartments.

Naoko Miura1, Masahiro Yamamoto, Masato Fukutake, Nobuhiro Ohtake, Seiichi Iizuka, Atsushi Ishige, Hiroshi Sasaki, Kazunori Fukuda, Tatsuo Yamamoto, Satoshi Hayakawa.   

Abstract

Recent studies have suggested that Fas-mediated apoptosis is involved in the pathogenesis of intestinal injury. In this study, we determined the role of Fas/Fas ligand (FasL) interactions in different T cell compartments using a murine model of small intestinal injury. An intraperitoneal injection of 145-2C11 (anti-CD3) antibody into C3H/HeN, BALB/c and MRL mice induced mucosal flattening and rapid, bi-phasic intestinal epithelial cell (IEC) apoptosis, which was detected by conventional light and electron microscopy and by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling. In the first, early phase, villous apoptosis was observed up to 4 h after injection, and in the second, later phase, apoptotic crypt cells gradually accumulated for up to 24 h. The early and later phases of apoptosis were reduced in lpr/lpr and nude mice compared with those in control strains. In addition, the kinetics of Fas-mediated killer activity induced by the antibody injection were different between intestinal intraepithelial lymphocytes (IEL) and splenocytes (SPL) and seemed to correlate with the bi-phasic occurrence of the apoptosis. Finally, the transfer of intestinal IEL from euthymic to nude mice induced both phases of apoptosis, whereas SPL induced the second phase's crypt apoptosis only by the antibody injection. Together, these results suggest the involvement of Fas-mediated killer activity of thymus-derived T cells in different compartments. Namely, T cell populations in different compartments are differentially involved in the induction of IEC apoptosis and contribute to the complex pathogenesis of immune-mediated intestinal injury in which Fas/FasL interactions may play a critical role.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778290     DOI: 10.1093/intimm/dxh231

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  11 in total

1.  Epithelial TNF Receptor Signaling Promotes Mucosal Repair in Inflammatory Bowel Disease.

Authors:  Emily M Bradford; Stacy H Ryu; Ajay Pal Singh; Goo Lee; Tatiana Goretsky; Preetika Sinh; David B Williams; Amber L Cloud; Elias Gounaris; Vihang Patel; Olivia F Lamping; Evan B Lynch; Mary Pat Moyer; Isabelle G De Plaen; David J Shealy; Guang-Yu Yang; Terrence A Barrett
Journal:  J Immunol       Date:  2017-07-26       Impact factor: 5.422

2.  Feeding mode influences dynamic gut microbiota signatures and affects susceptibility to anti-CD3 mAb-induced intestinal injury in neonatal mice.

Authors:  Saravanan Subramanian; Hua Geng; Chao Du; Pauline M Chou; Heng-Fu Bu; Xiao Wang; Suchitra Swaminathan; Stephanie C Tan; Jason M Ridlon; Isabelle G De Plaen; Xiao-Di Tan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-07-12       Impact factor: 4.871

3.  RNA binding protein DDX5 directs tuft cell specification and function to regulate microbial repertoire and disease susceptibility in the intestine.

Authors:  Tianyun Long; Nazia Abbasi; Juan E Hernandez; Yuxin Li; Ibrahim M Sayed; Shengyun Ma; Attilio Iemolo; Brian A Yee; Gene W Yeo; Francesca Telese; Pradipta Ghosh; Soumita Das; Wendy Jia Men Huang
Journal:  Gut       Date:  2021-12-01       Impact factor: 31.793

4.  Succinate Produced by Intestinal Microbes Promotes Specification of Tuft Cells to Suppress Ileal Inflammation.

Authors:  Amrita Banerjee; Charles A Herring; Bob Chen; Hyeyon Kim; Alan J Simmons; Austin N Southard-Smith; Margaret M Allaman; James R White; Mary C Macedonia; Eliot T Mckinley; Marisol A Ramirez-Solano; Elizabeth A Scoville; Qi Liu; Keith T Wilson; Robert J Coffey; M Kay Washington; Jeremy A Goettel; Ken S Lau
Journal:  Gastroenterology       Date:  2020-08-21       Impact factor: 22.682

5.  Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation.

Authors:  Monica Guma; Dariusz Stepniak; Helena Shaked; Martina E Spehlmann; Steve Shenouda; Hilde Cheroutre; Ildelfonso Vicente-Suarez; Lars Eckmann; Martin F Kagnoff; Michael Karin
Journal:  J Exp Med       Date:  2011-08-08       Impact factor: 14.307

6.  Paneth cell extrusion and release of antimicrobial products is directly controlled by immune cell-derived IFN-γ.

Authors:  Henner F Farin; Wouter R Karthaus; Pekka Kujala; Maryam Rakhshandehroo; Gerald Schwank; Robert G J Vries; Eric Kalkhoven; Edward E S Nieuwenhuis; Hans Clevers
Journal:  J Exp Med       Date:  2014-06-30       Impact factor: 14.307

7.  TU-100 (Daikenchuto) and ginger ameliorate anti-CD3 antibody induced T cell-mediated murine enteritis: microbe-independent effects involving Akt and NF-κB suppression.

Authors:  Nobuhiro Ueno; Takumu Hasebe; Atsushi Kaneko; Masahiro Yamamoto; Mikihiro Fujiya; Yutaka Kohgo; Toru Kono; Chong-Zhi Wang; Chun-Su Yuan; Marc Bissonnette; Eugene B Chang; Mark W Musch
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

8.  Involvement of interleukin-17A-induced hypercontractility of intestinal smooth muscle cells in persistent gut motor dysfunction.

Authors:  Hirotada Akiho; Yohei Tokita; Kazuhiko Nakamura; Kazuko Satoh; Mitsue Nishiyama; Naoko Tsuchiya; Kazuaki Tsuchiya; Katsuya Ohbuchi; Yoichiro Iwakura; Eikichi Ihara; Ryoichi Takayanagi; Masahiro Yamamoto
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

9.  Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche.

Authors:  Ysbrand M Nusse; Adam K Savage; Pauline Marangoni; Axel K M Rosendahl-Huber; Tyler A Landman; Frederic J de Sauvage; Richard M Locksley; Ophir D Klein
Journal:  Nature       Date:  2018-06-27       Impact factor: 69.504

10.  Evaluation of crypt apoptotic bodies and apoptotic indices in pediatric celiac disease by routine staining and H2AX immunostaining.

Authors:  Sarah Adel Hakim; Dalia Abd El-Kareem
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.